{{knowledge objective
|Identifiant=OIC-344-09-B
|Item_parent=Management of a patient with pre-eclampsia
|Item_parent_short=Management of a patient with pre-eclampsia
|Rank=B
|Title=Knowing the principles of preventing complications of pre-eclampsia
|Description=Method of treatment with magnesium sulphate, monitoring the efficacy and tolerance of magnesium sulphate.
|Rubric=Management
|Contributors=Merc√© Jourdain,Vassilis Tsatsaris
|Order=9}}

Blood pressure control to prevent cerebrovascular complications

Magnesium sulphate for the primary or secondary prevention of eclampsia

Magnesium sulphate for the prevention of neurological sequelae of prematurity (periventricular leukomalacia and intraventricular haemorrhage) in the event of delivery before 32 weeks' gestation.

Corticosteroid therapy for the prevention of neonatal complications associated with prematurity.

Delivery in the event of a life-threatening maternal or foetal condition